P Ravani
Overview
Explore the profile of P Ravani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scolari F, Ravani P, Gaggi R, Santostefano M, Rollino C, Stabellini N, et al.
Clin J Am Soc Nephrol
. 2023 Mar;
3(2):317-323.
PMID: 37001143
No abstract available.
2.
Bertelli R, Bonanni A, Di Donato A, Cioni M, Ravani P, Ghiggeri G
Clin Exp Immunol
. 2015 Jul;
183(2):166-74.
PMID: 26147676
Minimal change nephrosis (MCN) is an important cause of morbidity in children. In spite of successful therapies having been developed in the last three decades, most aspects related to pathogenesis...
3.
Schroijen M, van de Luijtgaarden M, Noordzij M, Ravani P, Jarraya F, Collart F, et al.
Diabetologia
. 2013 Jun;
56(9):1949-57.
PMID: 23771173
Aims/hypothesis: A previous study in Dutch dialysis patients showed no survival difference between patients with diabetes as primary renal disease and those with diabetes as a co-morbid condition. As this...
4.
Ocak G, van Stralen K, Rosendaal F, Verduijn M, Ravani P, Palsson R, et al.
J Thromb Haemost
. 2012 Sep;
10(12):2484-93.
PMID: 22970891
Background: It is has been suggested that dialysis patients have lower mortality rates for pulmonary embolism than the general population, because of platelet dysfunction and bleeding tendency. However, there is...
5.
Besarab A, Ravani P, Spergel L, Roy-Chaudhury P, Asif A
J Nephrol
. 2007 Nov;
20(6):668-73.
PMID: 18046668
Several research questions are open in the field of vascular access for hemodialysis. The present paper reviews both prognostic issues, such as the identification of factors for patient stratification before...
6.
Besarab A, Asif A, Roy-Chaudhury P, Spergel L, Ravani P
J Nephrol
. 2007 Nov;
20(6):656-67.
PMID: 18046667
In the past 5 years, some clinical trials have questioned the value of surveillance in managing vascular accesses. Although prolongation of access life span is an important end point, reduction...
7.
Ravani P, Tripepi G, Pecchini P, Mallamaci F, Malberti F, Zoccali C
Kidney Int
. 2007 Oct;
73(1):95-101.
PMID: 17943084
Urotensin II (UTN), a cyclic vasoactive peptide expressed in multiple organs, had higher plasma levels that was previously shown to predict longer survival in dialysis patients. We sought to determine...
8.
Ravani P, Marcelli D, Pecchini P, Malberti F
J Vasc Access
. 2007 Jul;
2(4):154-60.
PMID: 17638280
Maintenance and complications of vascular access (VA) for hemodialysis (HD) represent the leading cause of morbidity and health care cost among end stage renal disease population. To define the reasons...
9.
Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E
J Vasc Access
. 2007 Jul;
2(3):106-9.
PMID: 17638270
Unlabelled: Permanent dual lumen catheters (PDLC) provide an alternative vascular access in patients considered unsuitable for arteriovenous fistula, graft or peritoneal dialysis. However, the use of PDLC is often complicated...
10.
Mandolfo S, Bucci R, Ravani P, Imbasciati E
J Vasc Access
. 2007 Jul;
1(4):139-43.
PMID: 17638244
A growing number of elderly patients have started dialytic treatment in recent years. In spite of this fact, there is very little literature on dialysis prescription in these patients. In...